Lorazepam vs diazepam for pediatric status epilepticus: A randomized clinical trial

Authors

James M. Chamberlain, George Washington UniversityFollow
Pamela Okada, University of Texas Southwestern Medical Center at Dallas
Maija Holsti, University of Utah
Kathleen M. Brown, George Washington UniversityFollow
Cheryl Vance, University of California - Davis
Victor Gonzalez, Baylor College of Medicine
Richard Lichenstein, University of Maryland - Baltimore
Rachel Stanley, University of MichiganFollow
David C. Brousseau, Medical College of Wisconsin
Joseph Grubenhoff, Children's Hospital of Denver
Roger Zemek, Children's Hospital of Eastern Ontario, Ottawa, ON
David W. Johnson, Alberta Children's Hospital, Calgary, AB
Jill Baren, Children's Hospital of Philadelphia

Document Type

Journal Article

Publication Date

2014

Journal

JAMA - Journal of the American Medical Association

Volume

Volume 311, Issue 16

Inclusive Pages

1652-1660

Keywords

Anticonvulsants--therapeutic use; Diazepam--therapeutic use; Lorazepam--therapeutic use; Status Epilepticus--drug therapy

APA Citation

Chamberlain, J.M., Okada, P., Holsti, M., Mahajan, P., Brown, K.M. et al. (2014). Lorazepam vs diazepam for pediatric status epilepticus: A randomized clinical trial. JAMA - Journal of the American Medical Association, 311(16), 1652-1660.

Peer Reviewed

1